HOME › DRUGS › SATRAPLATIN
ACTIVE SUBSTANCE / INN

SATRAPLATIN

Brand name(s): Orplatna
EMA LISTED
APPLICATION WITHDRAWN
Prostatic Neoplasms
ACTIVE SUBSTANCE
Satraplatin
REGULATORS
EMA
SPONSORS / MAH
Pharmion Ltd.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OrplatnaPharmion Ltd.Application withdrawnProstatic Neoplasms

FULL INTELLIGENCE ON SATRAPLATIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →